Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143746 |
| CAS No | 614-95-9 |
| Mol.F. | C5H10N2O3 |
| Mol.Wt. | 146.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143747 |
| CAS No | 51542-33-7 |
| Mol.F. | C9H8N4O2S |
| Mol.Wt. | 236.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143748 |
| CAS No | 937-25-7 |
| Mol.F. | C7H7FN2O |
| Mol.Wt. | 154.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143749 |
| CAS No | 640-01-7 |
| Mol.F. | C9H16N2O2 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143750 |
| CAS No | 1522054-05-2 |
| Mol.F. | C3H7N3O3S |
| Mol.Wt. | 165.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143751 |
| CAS No | NA |
| Mol.F. | C6D14N2O |
| Mol.Wt. | 144.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143752 |
| CAS No | 99389-11-4 |
| Mol.F. | C5H6D4N2O |
| Mol.Wt. | 118.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143753 |
| CAS No | 1821341-18-7 |
| Mol.F. | C7H3D5N2O |
| Mol.Wt. | 141.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143754 |
| CAS No | 1173019-53-8 |
| Mol.F. | C4H2D8N2O3 |
| Mol.Wt. | 142.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143755 |
| CAS No | 960049-21-2 |
| Mol.F. | C5D10N2O |
| Mol.Wt. | 124.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143756 |
| CAS No | 1219802-09-1 |
| Mol.F. | C4D8N2O |
| Mol.Wt. | 108.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143757 |
| CAS No | 93951-96-3 |
| Mol.F. | C6D14N2O |
| Mol.Wt. | 144.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143758 |
| CAS No | 1219805-76-1 |
| Mol.F. | C4D8N2O2 |
| Mol.Wt. | 124.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143759 |
| CAS No | 91632-86-9 |
| Mol.F. | C7H5D3N2O |
| Mol.Wt. | 139.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143760 |
| CAS No | NA |
| Mol.F. | C6H5D8N3O2 |
| Mol.Wt. | 167.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143761 |
| CAS No | NA |
| Mol.F. | C17H17D3N2O2 |
| Mol.Wt. | 287.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |